COMP <GO>
VMI vs TMO // FORWARD P/E MULTIPLE
Valmont Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: VMI 7
— TMO 8
▲ FORWARD P/E MULTIPLE LEADER: VMI
LAST: $422.10 (-2.46%) • MKT CAP: $8.28B
forward-pe
21.9x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VMI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VMI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.20% | 41.00% | -10.80 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.70% | 9.30% | +5.40 | VMI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 30.4x | -13.90 | VMI | /valuation <GO> |
| Free Cash Flow Yield | 3.76% | 2.40% | +1.36 | VMI | /fcf-yield <GO> |
| Operating Margin | 10.10% | 17.40% | -7.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 15.10% | -6.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 0.70% | 3.90% | -3.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.63% | 0.24% | +0.39 | VMI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.17 | 4.50 | +1.67 | VMI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | VMI | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.1 | 59.1 | -29.09 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.94 | -0.04 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.9x | 36.3x | -14.40 | VMI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.28B | $262.22B | -$253.93B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VMI REV | TMO REV | VMI GROSS % | TMO GROSS % | VMI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.10B | $44.56B | 30.2% | 44.0% | $311.4M | $6.29B |
| FY 2024 | $4.08B | $42.88B | 30.5% | 44.0% | $493.2M | $7.27B |
| FY 2023 | $4.17B | $42.86B | 44.0% | 44.0% | $118.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VMI // BETA 0.90
TMO // BETA 0.94